CSF Concentration of Crizotinib in Two ALK-Positive Non-Small-Cell Lung Cancer Patients with CNS Metastases Deriving Clinical Benefit from Treatment
- PMID: 25898960
- DOI: 10.1097/JTO.0000000000000468
CSF Concentration of Crizotinib in Two ALK-Positive Non-Small-Cell Lung Cancer Patients with CNS Metastases Deriving Clinical Benefit from Treatment
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
